Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Gross Profit (2016 - 2025)

Lifecore Biomedical, Inc. \De\ (LFCR) has 16 years of Gross Profit data on record, last reported at $14.0 million in Q2 2025.

  • For Q2 2025, Gross Profit fell 19.04% year-over-year to $14.0 million; the TTM value through May 2025 reached $40.3 million, down 3.71%, while the annual FY2025 figure was $40.3 million, 3.71% down from the prior year.
  • Gross Profit reached $14.0 million in Q2 2025 per LFCR's latest filing, up from $9.8 million in the prior quarter.
  • Across five years, Gross Profit topped out at $17.3 million in Q2 2024 and bottomed at $2.7 million in Q3 2023.
  • Average Gross Profit over 5 years is $10.1 million, with a median of $10.4 million recorded in 2021.
  • Peak YoY movement for Gross Profit: tumbled 61.2% in 2022, then skyrocketed 122.02% in 2024.
  • A 5-year view of Gross Profit shows it stood at $14.6 million in 2021, then crashed by 61.2% to $5.7 million in 2022, then surged by 75.33% to $10.0 million in 2023, then increased by 11.32% to $11.1 million in 2024, then grew by 26.15% to $14.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Gross Profit were $14.0 million in Q2 2025, $9.8 million in Q1 2025, and $11.1 million in Q4 2024.